Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

Published:2020-01 Issue:1 Volume:26 Page:e7-e15
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Holstein Sarah A.,Al-Kadhimi Zaid,Costa Luciano J.,Hahn Theresa,Hari Parameswaran,Hillengass Jens,Jacob Allison,Munshi Nikhil C.,Oliva Stefania,Pasquini Marcelo C.,Shi Qian,Stadtmauer Edward A.,Waldvogel Stephanie L.,McCarthy Philip L.

Funder

Amgen

Celgene.

Celgene

Bristol-Myers Squibb

Novartis

Sanofi.

Sanofi

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference85 articles.

1. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma;Kumar;Lancet Oncol,2016

2. Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition;Stetler-Stevenson;Cytometry B Clin Cytom,2016

3. Association of minimal residual disease with superior survival outcomes in patients with multiple myeloma: a meta-analysis;Munshi;JAMA Oncol,2017

4. Should overall survival remain an endpoint for multiple myeloma trials?;Holstein;Curr Hematol Malig Rep,2019

5. Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT;Ho;Blood Advances,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune profiles to predict bortezomib-based treatment response for multiple myeloma patients;International Immunopharmacology;2024-03

2. Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma;Blood Cancer Journal;2023-09-05

3. Liquid biopsies and minimal residual disease in lymphoid malignancies;Frontiers in Oncology;2023-05-09

4. Immune profiles in Bone marrow to predict induce therapy response for multiple myeloma patients;2022-11-15

5. Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma;Transplantation and Cellular Therapy;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3